Last reviewed · How we verify

Corticosteroid (CS)

AbbVie · FDA-approved active Small molecule

Corticosteroids suppress the immune system and reduce inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Corticosteroids suppress the immune system and reduce inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for Inflammatory and autoimmune disorders (e.g., rheumatoid arthritis, lupus, vasculitis), Allergic and respiratory conditions (e.g., asthma, allergic rhinitis), Adrenal insufficiency.

At a glance

Generic nameCorticosteroid (CS)
SponsorAbbVie
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaImmunology, Rheumatology, Endocrinology
PhaseFDA-approved

Mechanism of action

Corticosteroids work by entering cells and binding to intracellular glucocorticoid receptors, which then translocate to the nucleus and modulate gene expression. This leads to decreased production of inflammatory mediators (cytokines, chemokines, adhesion molecules) and suppression of immune cell activation and proliferation. The result is broad anti-inflammatory and immunosuppressive effects across multiple tissues.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results